Când viaţa câştigă

08 august 2016

Emoţie… emoţie… pe ecranul ecografului se vede un punct. Un punct care bate. Încă o mişcare şi…da! Este inima Anastasiei, o nouă viaţă ce porneşte la drum. O viaţă ce va schimba vieţi.

Anastasia s-a născut în anul 2011 în Bucureşti. A adus bucurie în familie şi multe lacrimi de fericire. Câţiva ani mai târziu Anastasia a adus şi lacrimi de neputinţă. Fără să depindă ceva de ea, fără că părinţii să poată face ceva înainte, Anastasia a aflat că suferă de tetrapareză cerebrală infantilă formă spastică distonică bilaterală, o boală cauzată de lipsa oxigenării creierului pentru un interval de timp, la naştere.

Toamna lui 2015

În casa Anastasiei este acum linişte, micuţa doarme iar părinţii ei sunt în bucătărie. Telefonul le aduce o veste neaşteptată şi în acelaşi timp greu de înţeles. Anastasia ar putea face parte din echipa celor care creează medicină viitorului. Anastasia poate fi un deschizător de drumuri, un copil care poate scrie istorie. Celulele stem recoltate de mama la naşterea ei, ar putea să fie puse la treabă şi să ajute în tratamentul de care suferă acum micuţa.

Suntem singurul grup de bănci de celule stem din Uniunea Europeana ce are propriul centru de transplant!

Ai putea să refuzi o asemenea ştire? Ai putea oare să spui că nu vrei să încerci? Mama Anastasiei a spus DA!

…şi aventura începe

În toamna anului 2015, Anastasia merge pentru prima dată în Polonia, la spitalul Spitalul Universitar de Copii din Cracovia, ajutată de către Biogenis, banca de celule stem unde are stocate acum şi celulele stem. Fetiţa primeşte prima infuzie cu celule stem şi pleacă acasă chiar a doua zi după intervenţie.

După doar două săptămâni, părinţii Anastasiei observă şi primele rezultate pozitive. Pentru prima dată, Anastasia spune mama, pentru că mai apoi fetiţa să poată mânca, să poată înghiţi, să-şi îmbunătăţească motricitatea. Mai are un drum lung de parcus însă speranţa a prins aripi şi merge mai departe. Anul acesta Anastasia a fost din nou în Polonia şi a mai făcut o intervenţie. Cu siguranţă vor urmă şi altele. Cu toţii ne dorim să vedem rezultatele cât mai repede, încurajaţi fiind şi de sutele de oameni care fac un tratament cu celule stem chiar acum, în grupul de bănci de celule stem din care face parte şi Biogenis, banca ce a stocat pentru prima dată celulele stem ale Anastasiei. 564 de pacienţi sunt trataţi acum în acest grup, prin terapii standard şi experimentale, încercându-se o rezolvare pentru boli precum epilepsie, Alzheimer, autism, scleroză laterală, paralizie cerebrală, scleroză multiplă, encefalopatie, orbire…

Cand viata castiga, nimic nu te mai poate opri. Cand viata castiga, te bucuri ca ai facut ce trebuia, ii inveti si pe altii si aduci bucurie la randul tau.

Poţi vedea poveştile Biogenis pe www.biogenis.ro/candviatacastiga

Biogenis, mai mult decât o bancă de celule stem.

Lista cu utilizări în grupul din care face parte Biogenis

No. Cell source Indication Area of medicine Year Type of therapy Country Age
1 cord blood acute lymphoblastic leukemia hematology 2016 standard therapy Hungary 7
2 cord blood autism neurology 2016 experimental therapy Poland 6
3 cord blood acute myeloid leukemia hematology 2016 standard therapy Jordan 6
4 cord blood acute lymphoblastic leukemia hematology 2015 standard therapy Poland 4
5 cord blood acute lymphoblastic leukemia hematology 2014 standard therapy Turkey 7
6 cord blood aplastic anaemia hematology 2013 standard therapy Poland 3
7 cord blood acute myeloid leukemia hematology 2013 standard therapy Poland 3
8 cord blood beta-talassemia; agranulocytosis hematology 2013 standard therapy Turkey 8
9 cord blood X – linked lymphoproliferative syndrome hematology 2013 standard therapy Poland 10/12
10 cord blood severe aplastic anaemia hematology 2012 standard therapy Hungary 3
11 cord blood anaemia, talassemia major hematology 2012 standard therapy Turkey 6
12 cord blood talassemia major, acute lymphoblastic leukemia hematology 2012 standard therapy Turkey 3,5
13 cord blood T-acute lymphoblastic leukemia hematology 2012 standard therapy Turkey 5
14 cord blood Fanconi anemia hematology 2011 standard therapy Poland 12
15 cord blood acute myeloid leukemia hematology 2011 standard therapy Hungary 2
16 cord blood acute lymphoblastic leukemia hematology 2011 standard therapy Poland 5
17 cord blood histiocytosis hematology 2011 standard therapy Poland 2,5
18 cord blood chronic granulomatous disease hematology 2011 standard therapy Poland 7,5
19 cord blood pre -B acute lymphoblastic leukemia hematology 2010 standard therapy Hungary 1,5
20 cord blood myelodysplastic syndrome hematology 2009 standard therapy Poland 5
21 cord blood acute lymphoblastic leukemia hematology 2008 standard therapy Poland 5
22 cord blood cerebral ischemia neurology 2008 experimental therapy Poland 1,5
23 cord blood neuroblastoma hematology 2007 standard therapy Poland 8
24 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 2,10
25 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 10,11
26 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 44,5
27 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 60,8
28 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 32,2
29 cord tissue (Wharton's jelly) spinocerebellar ataxia neurology 2016 experimental therapy Poland 64
30 cord tissue (Wharton's jelly) spinocerebellar ataxia neurology 2016 experimental therapy Poland 62,5
31 cord tissue (Wharton's jelly) autism neurology 2016 experimental therapy Poland 18,4
32 cord tissue (Wharton's jelly) dystrophia progressiva pseudohypertrophica neurology 2016 experimental therapy Poland 48,8
33 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 10,3
34 cord tissue (Wharton's jelly) facio-scapulo-humeral muscular dystrophy neurology 2016 experimental therapy Poland 35,3
35 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 53,7
36 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 12,2
37 cord tissue (Wharton's jelly) delayed psychomotor development neurology 2016 experimental therapy Poland 3,10
38 cord tissue (Wharton's jelly) acute graft versus host disease hematology 2016 experimental therapy Poland 14
39 cord tissue (Wharton's jelly) acute graft versus host disease hematology 2016 experimental therapy Poland 6
40 cord tissue (Wharton's jelly) gonarthrosis orthopedics 2016 experimental therapy Poland 65,8
41 cord tissue (Wharton's jelly) leukodystrophy neurology 2016 experimental therapy Poland 2,9
42 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 59,4
43 cord tissue (Wharton's jelly) autism neurology 2016 experimental therapy Poland 6
44 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 2,11
45 cord tissue (Wharton's jelly) autism neurology 2016 experimental therapy Poland 12,11
46 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 9,7
47 cord tissue (Wharton's jelly) atrophy of the optic nerves ophthalmology 2016 experimental therapy Poland 20,3
48 cord tissue (Wharton's jelly) Stargardt's disease ophthalmology 2016 experimental therapy Poland 53
49 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2016 experimental therapy Poland 33,5
50 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2016 experimental therapy Poland 22,2
51 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 10,3
52 cord tissue (Wharton's jelly) autism neurology 2016 experimental therapy Poland 8,5
53 cord tissue (Wharton's jelly) sclerosis multiplex neurology 2016 experimental therapy Poland 29,11
54 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 33,4
55 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 37,4
56 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 39,3
57 cord tissue (Wharton's jelly) autism neurology 2016 experimental therapy Poland 7,11
58 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2016 experimental therapy Poland 28
59 cord tissue (Wharton's jelly) gonarthrosis orthopedics 2016 experimental therapy Poland 69,6
60 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2016 experimental therapy Poland 33,11
61 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2016 experimental therapy Poland 20,7
62 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2016 experimental therapy Poland 24,5
63 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2016 experimental therapy Poland 25,6
64 cord tissue (Wharton's jelly) autism neurology 2016 experimental therapy Poland 8,5
65 cord tissue (Wharton's jelly) facio-scapulo-humeral muscular dystrophy neurology 2016 experimental therapy Poland 39,10
66 cord tissue (Wharton's jelly) patella cartilage damage orthopedics 2016 experimental therapy Poland 60,10
67 cord tissue (Wharton's jelly) autism neurology 2016 experimental therapy Poland 6,9
68 cord tissue (Wharton's jelly) sclerosis multiplex neurology 2016 experimental therapy Poland 44,8
69 cord tissue (Wharton's jelly) facio-scapulo-humeral muscular dystrophy neurology 2016 experimental therapy Poland 25,4
70 cord tissue (Wharton's jelly) autism neurology 2016 experimental therapy Poland 10,10
71 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 63,2
72 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 54,11
73 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 53,9
74 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 46,9
75 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 58
76 cord tissue (Wharton's jelly) chronic graft versus host disease hematology 2016 experimental therapy Poland 19,2
77 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 55
78 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 58,1
79 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 61,7
80 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 52,6
81 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 59,11
82 cord tissue (Wharton's jelly) tetraparesis spastica orthopedics 2016 experimental therapy Poland 28,8
83 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 60,9
84 cord tissue (Wharton's jelly) spinal muscular atrophy neurology 2016 experimental therapy Poland 34,9
85 cord tissue (Wharton's jelly) gonarthrosis orthopedics 2016 experimental therapy Poland 69,3
86 cord tissue (Wharton's jelly) tetraparesis spastica orthopedics 2016 experimental therapy Poland 47,9
87 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2016 experimental therapy Poland 18,8
88 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 2,9
89 cord tissue (Wharton's jelly) traumatic brain injury neurology 2016 experimental therapy Poland 54,9
90 cord tissue (Wharton's jelly) epilepsia neurology 2016 experimental therapy Poland 19,5
91 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 59
92 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 66,9
93 cord tissue (Wharton's jelly) tetraparesis orthopedics 2016 experimental therapy Poland 27,9
94 cord tissue (Wharton's jelly) epilepsia neurology 2016 experimental therapy Poland 14,9
95 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 42,7
96 cord tissue (Wharton's jelly) acute graft versus host disease hematology 2016 experimental therapy Poland 60,5
97 cord tissue (Wharton's jelly) autism neurology 2016 experimental therapy Poland 6,2
98 cord tissue (Wharton's jelly) autism neurology 2016 experimental therapy Poland 11,3
99 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 9,11
100 cord tissue (Wharton's jelly) gonarthrosis orthopedics 2016 experimental therapy Poland 49,8
101 cord tissue (Wharton's jelly) optic atrophy ophthalmology 2016 experimental therapy Poland 69,9
102 cord tissue (Wharton's jelly) optic atrophy ophthalmology 2016 experimental therapy Poland 69,1
103 cord tissue (Wharton's jelly) epilepsia neurology 2016 experimental therapy Poland 13,11
104 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 45,1
105 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 53,4
106 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 36,1
107 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 59,1
108 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 66,2
109 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 49,7
110 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 55,1
111 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 46,1
112 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 72,4
113 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 54,3
114 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 56,1
115 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 61,8
116 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 64,7
117 cord tissue (Wharton's jelly) malformation syndrome neurology 2016 experimental therapy Poland 3,5
118 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 64,2
119 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2016 experimental therapy Poland 38
120 cord tissue (Wharton's jelly) autism neurology 2016 experimental therapy Poland 6,10
121 cord tissue (Wharton's jelly) encephalopathy neurology 2016 experimental therapy Poland 2,11
122 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 62,8
123 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 56,5
124 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 51,3
125 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 4,2
126 cord tissue (Wharton's jelly) sclerosis multiplex neurology 2016 experimental therapy Poland 55,4
127 cord tissue (Wharton's jelly) sclerosis multiplex neurology 2016 experimental therapy Poland 54,8
128 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 33,10
129 cord tissue (Wharton's jelly) sclerosis multiplex neurology 2016 experimental therapy Poland 41,4
130 cord tissue (Wharton's jelly) sclerosis multiplex neurology 2016 experimental therapy Poland 49,3
131 cord tissue (Wharton's jelly) choroideremia ophthalmology 2016 experimental therapy Poland 50,8
132 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2016 experimental therapy Poland 63,1
133 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2016 experimental therapy Poland 7,4
134 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 60,4
135 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 73,7
136 cord tissue (Wharton's jelly) leukodystrophy neurology 2016 experimental therapy Poland 2,11
137 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 61,6
138 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2016 experimental therapy Poland 48,3
139 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2016 experimental therapy Poland 32,7
140 cord tissue (Wharton's jelly) acute graft versus host disease hematology 2016 experimental therapy Poland 3,11
141 cord tissue (Wharton's jelly) sclerosis multiplex neurology 2016 experimental therapy Poland 61,11
142 cord tissue (Wharton's jelly) sclerosis multiplex neurology 2016 experimental therapy Poland 45,8
143 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 61,4
144 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 79,2
145 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 72,6
146 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 48,4
147 cord tissue (Wharton's jelly) adrenoleukodystrophy neurology 2016 experimental therapy Poland 6,11
148 cord tissue (Wharton's jelly) adrenoleukodystrophy neurology 2016 experimental therapy Poland 9,7
149 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 54,2
150 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 50,9
151 cord tissue (Wharton's jelly) limb-girdle muscular dystrophy neurology 2016 experimental therapy Poland 22
152 cord tissue (Wharton's jelly) epilepsia neurology 2016 experimental therapy Poland 14,7
153 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 55,9
154 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 62,6
155 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2016 experimental therapy Poland 58,10
156 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 12,6
157 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 66,2
158 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 55,9
159 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 49,4
160 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 55,7
161 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 58,1
162 cord tissue (Wharton's jelly) spina bifida neurology 2016 experimental therapy Poland 4,8
163 cord tissue (Wharton's jelly) spina bifida neurology 2016 experimental therapy Poland 1,5
164 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 3
165 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 9,9
166 cord tissue (Wharton's jelly) global developmental delay neurology 2016 experimental therapy Poland 6,9
167 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 66,8
168 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 39,6
169 cord tissue (Wharton's jelly) autism neurology 2016 experimental therapy Poland 13,2
170 cord tissue (Wharton's jelly) developmental delay neurology 2016 experimental therapy Poland 7,4
171 cord tissue (Wharton's jelly) spina bifida neurology 2016 experimental therapy Poland 7,4
172 cord tissue (Wharton's jelly) optic neuropathy ophthalmology 2016 experimental therapy Poland 66
173 cord tissue (Wharton's jelly) sclerosis multiplex neurology 2016 experimental therapy Poland 38,1
174 cord tissue (Wharton's jelly) autism neurology 2016 experimental therapy Poland 8,4
175 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 3
176 cord tissue (Wharton's jelly) optic neuropathy ophthalmology 2016 experimental therapy Poland 79,8
177 cord tissue (Wharton's jelly) spinocerebellar ataxia neurology 2016 experimental therapy Poland 54,3
178 cord tissue (Wharton's jelly) dystrophia progressiva pseudohypertrophica neurology 2016 experimental therapy Poland 14,4
179 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 47,11
180 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 49,3
181 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 61,2
182 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2016 experimental therapy Poland 23,6
183 cord tissue (Wharton's jelly) age-related macular degeneration ophthalmology 2016 experimental therapy Poland 86,5
184 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2016 experimental therapy Poland 54,6
185 cord tissue (Wharton's jelly) sclerosis multiplex neurology 2016 experimental therapy Poland 68,5
186 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 13,7
187 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 2,2
188 cord tissue (Wharton's jelly) autism neurology 2016 experimental therapy Poland 5,0
189 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 12,11
190 cord tissue (Wharton's jelly) autism neurology 2016 experimental therapy Poland 12,3
191 cord tissue (Wharton's jelly) spina bifida neurology 2016 experimental therapy Poland 1,3
192 cord tissue (Wharton's jelly) developmental delay neurology 2016 experimental therapy Poland 2,7
193 cord tissue (Wharton's jelly) spinal muscular atrophy neurology 2016 experimental therapy Poland 3,3
194 cord tissue (Wharton's jelly) facio-scapulo-humeral muscular dystrophy neurology 2016 experimental therapy Poland 59,6
195 cord tissue (Wharton's jelly) spinal muscular atrophy neurology 2016 experimental therapy Poland 34,2
196 cord tissue (Wharton's jelly) muscular dystrophy neurology 2016 experimental therapy Poland 30,3
197 cord tissue (Wharton's jelly) spinal muscular atrophy neurology 2016 experimental therapy Poland 17,10
198 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2016 experimental therapy Poland 37,11
199 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 31,9
200 cord tissue (Wharton's jelly) ataxia hereditaria neurology 2016 experimental therapy Poland 69
201 cord tissue (Wharton's jelly) muscular dystrophy neurology 2016 experimental therapy Poland 31,9
202 cord tissue (Wharton's jelly) no data ophthalmology 2016 experimental therapy Poland 66,1
203 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 53,4
204 cord tissue (Wharton's jelly) patella cartilage damage orthopedics 2016 experimental therapy Poland 60,8
205 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 10,8
206 cord tissue (Wharton's jelly) encephalopathy neurology 2016 experimental therapy Poland 3
207 cord tissue (Wharton's jelly) spina bifida neurology 2016 experimental therapy Poland 2,11
208 cord tissue (Wharton's jelly) encephalopathy neurology 2016 experimental therapy Poland 4,3
209 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2016 experimental therapy Poland no data
210 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2016 experimental therapy Poland 59,4
211 cord tissue (Wharton's jelly) atrophy of the optic nerves ophthalmology 2016 experimental therapy Poland 20,11
212 cord tissue (Wharton's jelly) patella cartilage damage orthopedics 2016 experimental therapy Poland 53
213 cord tissue (Wharton's jelly) autism neurology 2016 experimental therapy Poland 24,5
214 cord tissue (Wharton's jelly) dystrophia progressiva pseudohypertrophica neurology 2016 experimental therapy Poland 34, 7
215 cord tissue (Wharton's jelly) muscular dystrophy neurology 2016 experimental therapy Poland 32,3
216 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 65,9
217 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 52,7
218 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 71,5
219 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2016 experimental therapy Poland 60,7
220 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 1,10
221 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 7,6
222 cord tissue (Wharton's jelly) spinal muscular atrophy neurology 2016 experimental therapy Poland 1,10
223 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2016 experimental therapy Poland 29,7
224 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 68,5
225 cord tissue (Wharton's jelly) chronic graft versus host disease hematology 2016 experimental therapy Poland 8/12
226 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 44,5
227 cord tissue (Wharton's jelly) dystrophia progressiva pseudohypertrophica neurology 2016 experimental therapy Poland 9,2
228 cord tissue (Wharton's jelly) Stargardt's disease ophthalmology 2016 experimental therapy Poland 24,5
229 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 66,7
230 cord tissue (Wharton's jelly) spina bifida neurology 2016 experimental therapy Poland 15,9
231 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 6,8
232 cord tissue (Wharton's jelly) autism neurology 2016 experimental therapy Poland 10,3
233 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 16,4
234 cord tissue (Wharton's jelly) autism neurology 2016 experimental therapy Poland 6
235 cord tissue (Wharton's jelly) spinocerebellar ataxia neurology 2016 experimental therapy Poland 41,8
236 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 51,9
237 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 49,3
238 cord tissue (Wharton's jelly) autism neurology 2016 experimental therapy Poland 20,9
239 cord tissue (Wharton's jelly) fetal alcohol spectrum disorders neurology 2016 experimental therapy Poland 5,2
240 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 13,10
241 cord tissue (Wharton's jelly) tetraparesis spastica orthopedics 2016 experimental therapy Poland 58,4
242 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 68,2
243 cord tissue (Wharton's jelly) chondronecrosis femoral condyle orthopedics 2016 experimental therapy Poland 54,11
244 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 55,4
245 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 41,2
246 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 72,1
247 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 56,8
248 cord tissue (Wharton's jelly) spina bifida neurology 2016 experimental therapy Poland 2,11
249 cord tissue (Wharton's jelly) tetraparesis spastica orthopedics 2016 experimental therapy Poland 18
250 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 4,1
251 cord tissue (Wharton's jelly) acute graft versus host disease hematology 2015 experimental therapy Poland 1,4
252 cord tissue (Wharton's jelly) autism neurology 2015 experimental therapy Poland 5,4
253 cord tissue (Wharton's jelly) sclerosis multiplex neurology 2015 experimental therapy Poland 23,2
254 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 61,6
255 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 61
256 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 56
257 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 51
258 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 65
259 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 60
260 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 52
261 cord tissue (Wharton's jelly) cerebral palsy neurology 2015 experimental therapy Poland 3,8
262 cord tissue (Wharton's jelly) decerebration rigidity neurology 2015 experimental therapy Poland 9,6
263 cord tissue (Wharton's jelly) bilateral blindness
bilateral blindness
ophthalmology 2015 experimental therapy Poland 36,10
264 cord tissue (Wharton's jelly) acute graft versus host disease hematology 2015 experimental therapy Poland 11/12
265 cord tissue (Wharton's jelly) cerebral palsy neurology 2015 experimental therapy Poland 7,1
266 cord tissue (Wharton's jelly) cerebral palsy neurology 2015 experimental therapy Poland 15,8
267 cord tissue (Wharton's jelly) ceroid lipofuscinosis neurology 2015 experimental therapy Poland 5,1
268 cord tissue (Wharton's jelly) encephalopathy neurology 2015 experimental therapy Poland 14,5
269 cord tissue (Wharton's jelly) ceroid lipofuscinosis neurology 2015 experimental therapy Poland 7,10
270 cord tissue (Wharton's jelly) autism neurology 2015 experimental therapy Poland 3
271 cord tissue (Wharton's jelly) cerebral palsy neurology 2015 experimental therapy Poland 7,1
272 cord tissue (Wharton's jelly) cerebral palsy neurology 2015 experimental therapy Poland 13,1
273 cord tissue (Wharton's jelly) spina bifida neurology 2015 experimental therapy Poland 2,4
274 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 59,4
275 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2015 experimental therapy Poland 31,2
276 cord tissue (Wharton's jelly) cerebral palsy neurology 2015 experimental therapy Poland 5,1
277 cord tissue (Wharton's jelly) autism neurology 2015 experimental therapy Poland 12,5
278 cord tissue (Wharton's jelly) cerebral palsy neurology 2015 experimental therapy Poland 8,11
279 cord tissue (Wharton's jelly) delayed psychomotor development, deafness neurology 2015 experimental therapy Poland 3,3
280 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 61,5
281 cord tissue (Wharton's jelly) traumatic encephalopathy neurology 2015 experimental therapy Poland 20,11
282 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2015 experimental therapy Poland 18,8
283 cord tissue (Wharton's jelly) cerebral palsy neurology 2015 experimental therapy Poland 2,7
284 cord tissue (Wharton's jelly) adrenoleukodystrophy; encephalopathy neurology 2015 experimental therapy Poland 23
285 cord tissue (Wharton's jelly) adrenoleukodystrophy neurology 2015 experimental therapy Poland 11,11
286 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2015 experimental therapy Poland 40
287 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2015 experimental therapy Poland 26,1
288 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2015 experimental therapy Poland 37,1
289 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 58
290 cord tissue (Wharton's jelly) spinocerebellar ataxia neurology 2015 experimental therapy Poland 35,6
291 cord tissue (Wharton's jelly) spinal muscular atrophy neurology 2015 experimental therapy Poland 11/12
292 cord tissue (Wharton's jelly) spinocerebellar ataxia neurology 2015 experimental therapy Poland 44,6
293 cord tissue (Wharton's jelly) optic neuropathy ophthalmology 2015 experimental therapy Poland 15,8
294 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 61,6
295 cord tissue (Wharton's jelly) gonarthrosis orthopedics 2015 experimental therapy Poland 66,2
296 cord tissue (Wharton's jelly) iatrogenic spinal cord injury neurology 2015 experimental therapy Poland 17,2
297 cord tissue (Wharton's jelly) optic neuropathy ophthalmology 2015 experimental therapy Poland 45,10
298 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 62
299 cord tissue (Wharton's jelly) acute graft versus host disease hematology 2015 experimental therapy Poland 51,5
300 cord tissue (Wharton's jelly) cerebral palsy neurology 2015 experimental therapy Poland 12,10
301 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 26,5
302 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 27
303 cord tissue (Wharton's jelly) cerebral palsy neurology 2015 experimental therapy Poland 4,10
304 cord tissue (Wharton's jelly) autism neurology 2015 experimental therapy Poland 6,1
305 cord tissue (Wharton's jelly) autism neurology 2015 experimental therapy Poland 4,6
306 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 63,11
307 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2015 experimental therapy Poland 32,10
308 cord tissue (Wharton's jelly) cerebral palsy neurology 2015 experimental therapy Poland 22
309 cord tissue (Wharton's jelly) sclerosis multiplex neurology 2015 experimental therapy Poland 33,3
310 cord tissue (Wharton's jelly) delayed psychomotor development neurology 2015 experimental therapy Poland 3,6
311 cord tissue (Wharton's jelly) spina bifida neurology 2015 experimental therapy Poland 2
312 cord tissue (Wharton's jelly) cerebellar ataxia neurology 2015 experimental therapy Poland 18,7
313 cord tissue (Wharton's jelly) spinocerebellar ataxia neurology 2015 experimental therapy Poland 24,3
314 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 67,6
315 cord tissue (Wharton's jelly) autism neurology 2015 experimental therapy Poland 5,6
316 cord tissue (Wharton's jelly) polineuropathy neurology 2015 experimental therapy Poland 74,2
317 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 37,6
318 cord tissue (Wharton's jelly) stroke neurology 2015 experimental therapy Poland 62,8
319 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 58,10
320 cord tissue (Wharton's jelly) facio-scapulo-humeral muscular dystrophy neurology 2015 experimental therapy Poland 30,1
321 cord tissue (Wharton's jelly) chronic graft versus host disease hematology 2015 experimental therapy Poland 10
322 cord tissue (Wharton's jelly) severe developmental delay neurology 2015 experimental therapy Poland 1,1
323 cord tissue (Wharton's jelly) spinal muscular atrophy neurology 2015 experimental therapy Poland 26,2
324 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 46,2
325 cord tissue (Wharton's jelly) autism neurology 2015 experimental therapy Poland 8,7
326 cord tissue (Wharton's jelly) encephalopathy neurology 2015 experimental therapy Poland 8/12
327 cord tissue (Wharton's jelly) acute graft versus host disease hematology 2015 experimental therapy Poland 6,6
328 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 48,7
329 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2015 experimental therapy Poland 21,4
330 cord tissue (Wharton's jelly) cerebral palsy neurology 2015 experimental therapy Poland 9,9
331 cord tissue (Wharton's jelly) acute graft versus host disease hematology 2015 experimental therapy Poland 13,4
332 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 61,3
333 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 54
334 cord tissue (Wharton's jelly) intracranial injury neurology 2015 experimental therapy Poland 24,3
335 cord tissue (Wharton's jelly) stroke neurology 2015 experimental therapy Poland 54,9
336 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2015 experimental therapy Poland 24,7
337 cord tissue (Wharton's jelly) gonarthrosis orthopedics 2015 experimental therapy Poland 65,9
338 cord tissue (Wharton's jelly) leukodystrophy neurology 2015 experimental therapy Poland 18,8
339 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2015 experimental therapy Poland 34,4
340 cord tissue (Wharton's jelly) cerebral palsy neurology 2015 experimental therapy Poland 1,6
341 cord tissue (Wharton's jelly) cerebral palsy neurology 2015 experimental therapy Poland 14,10
342 cord tissue (Wharton's jelly) anterior ischemic optic neuropathy ophthalmology 2015 experimental therapy Poland 54,10
343 cord tissue (Wharton's jelly) cerebral palsy neurology 2015 experimental therapy Poland 16,9
344 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2015 experimental therapy Poland 34,5
345 cord tissue (Wharton's jelly) cerebellar ataxia neurology 2015 experimental therapy Poland 26,1
346 cord tissue (Wharton's jelly) encephalopathy neurology 2015 experimental therapy Poland 11,2
347 cord tissue (Wharton's jelly) adrenoleukodystrophy; encephalopathy neurology 2015 experimental therapy Poland 8,4
348 cord tissue (Wharton's jelly) neuropathy neurology 2014 experimental therapy Poznań 23,6
349 cord tissue (Wharton's jelly) autism neurology 2014 experimental therapy Poland 12,6
350 cord tissue (Wharton's jelly) acute graft versus host disease hematology 2014 experimental therapy Poland 6
351 cord tissue (Wharton's jelly) central motor coordination impairment after hypoxic ischaemia lesion at birth neurology 2014 experimental therapy Poland 2,1
352 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2014 experimental therapy Poland 60,10
353 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2014 experimental therapy Poland 24,1
354 cord tissue (Wharton's jelly) autism neurology 2014 experimental therapy Poland 8,3
355 cord tissue (Wharton's jelly) muscular dystrophy neurology 2014 experimental therapy Poland 6
356 cord tissue (Wharton's jelly) birth asphyxia; retinopathy neurology 2014 experimental therapy Poland 11/12
357 cord tissue (Wharton's jelly) cerebral palsy neurology 2014 experimental therapy Poland 4,10
358 cord tissue (Wharton's jelly) cerebral palsy neurology 2014 experimental therapy Poland 15,10
359 cord tissue (Wharton's jelly) acute graft versus host disease hematology 2013 experimental therapy Poland 18,9
360 cord tissue (Wharton's jelly) acute graft versus host disease hematology 2013 experimental therapy Poland 2,11
361 cord tissue (Wharton's jelly) acute graft versus host disease hematology 2013 experimental therapy Poland 3,5
362 cord tissue (Wharton's jelly) acute myeloid leukemia hematology 2013 experimental therapy Poland 3,5
363 cord tissue (Wharton's jelly) chronic graft versus host disease hematology 2013 experimental therapy Poland 18,8
364 cord tissue (Wharton's jelly) chronic graft versus host disease hematology 2013 experimental therapy Poland 17,5
365 cord tissue (Wharton's jelly) acute graft versus host disease hematology 2012 experimental therapy Poland 19,7
366 cord tissue (Wharton's jelly) acute graft versus host disease hematology 2012 experimental therapy Poland 7,1
367 cord tissue (Wharton's jelly) acute graft versus host disease hematology 2012 experimental therapy Poland 4,3
368 cord tissue (Wharton's jelly) acute graft versus host disease hematology 2011 experimental therapy Poland 17,2
369 bone marrow acute myelogenous leukemia hematology 2016 standard therapy United Kingdom 58
370 peripheral blood acute lymphoblastic leukemia hematology 2016 standard therapy Poland 56
371 bone marrow osteopetrosis metabolic 2016 standard therapy Russia 6
372 bone marrow severe combined immunodeficiency hematology 2016 standard therapy Romania 2
373 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy Austria 60
374 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Australia 62
375 peripheral blood no data n/a 2016 standard therapy Czech Republic 45
376 peripheral blood chronic lymphocytic leukemia hematology 2016 standard therapy Slovakia 52
377 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy France 40
378 peripheral blood no data n/a 2016 standard therapy Netherlands 70
379 peripheral blood no data n/a 2016 standard therapy Poland 43
380 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Poland 18
381 peripheral blood X-linked lymphoproliferative disease hematology 2016 standard therapy Russia 12
382 peripheral blood chronic lymphocytic leukemia hematology 2016 standard therapy Sweden 61
383 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Germany 66
384 peripheral blood no data n/a 2016 standard therapy Netherlands 69
385 peripheral blood acute lymphoblastic leukemia hematology 2016 standard therapy Columbia 43
386 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Germany 64
387 peripheral blood Hodgkin’s lymphoma hematology 2016 standard therapy Poland 31
388 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Czech Republic 54
389 peripheral blood T-cell leukemia/lymphoma hematology 2016 standard therapy Canada 31
390 bone marrow T-cell acute lymphoblastic leukemia hematology 2016 standard therapy Italy 4
391 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Poland 54
392 peripheral blood primary myelofibrosis hematology 2016 standard therapy Germany 50
393 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Poland 18
394 peripheral blood adrenoleukodystrophy metabolic 2016 standard therapy Poland 1
395 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Italy 31
396 peripheral blood no data n/a 2016 standard therapy Poland 28
397 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Sweden 35
398 bone marrow no data n/a 2016 standard therapy Italy 3
399 bone marrow acute myelogenous leukemia hematology 2016 standard therapy Italy 64
400 peripheral blood no data n/a 2016 standard therapy Czech Republic 1
401 peripheral blood Wiskott-Aldrich syndrome hematology 2016 standard therapy Poland 1
402 peripheral blood no data n/a 2016 standard therapy Belgium 30
403 bone marrow acute lymphoblastic leukemia hematology 2016 standard therapy Italy 9
404 bone marrow acute myelogenous leukemia hematology 2016 standard therapy Spain 55
405 bone marrow Fanconi anaemia hematology 2016 standard therapy Estonia 7
406 peripheral blood no data n/a 2016 standard therapy Germany 71
407 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Germany 46
408 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Germany 29
409 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy Czech Republic 56
410 bone marrow acute lymphoblastic leukemia hematology 2016 standard therapy Italy 6
411 bone marrow acute myelogenous leukemia hematology 2016 standard therapy Italy 64
412 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy France 32
413 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Czech Republic 49
414 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy Germany 50
415 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Poland 64
416 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Poland 42
417 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Germany 13
418 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Slovakia 8
419 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Belgium 46
420 peripheral blood refractory anemia with excess blasts hematology 2016 standard therapy United Kingdom 62
421 bone marrow acute lymphoblastic leukemia hematology 2016 standard therapy Italy 14
422 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Poland 40
423 peripheral blood myelodysplastic syndrome – RAEB hematology 2016 standard therapy Poland 56
424 peripheral blood no data n/a 2016 standard therapy Sweden 58
425 peripheral blood Hodgkin’s lymphoma hematology 2016 standard therapy Germany 32
426 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Germany 32
427 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Germany 66
428 peripheral blood T Cell Lymphoma/ NOS – Not otherwise specified hematology 2016 standard therapy Germany 55
429 bone marrow biphenotypic leukemia hematology 2016 standard therapy Brazil 27
430 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Germany 43
431 bone marrow acute lymphoblastic leukemia hematology 2016 standard therapy Germany 7
432 peripheral blood no data n/a 2016 standard therapy Czech Republic 59
433 peripheral blood aplastic anaemia hematology 2016 standard therapy United Kingdom 23
434 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy Germany 73
435 peripheral blood myelofibrosis hematology 2016 standard therapy Israel 72
436 peripheral blood acute lymphoblastic leukemia hematology 2016 standard therapy Australia 61
437 bone marrow osteopetrosis metabolic 2016 standard therapy Germany 1
438 peripheral blood primary myelofibrosis hematology 2016 standard therapy Germany 67
439 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy Ireland 47
440 peripheral blood no data n/a 2016 standard therapy Germany 17
441 peripheral blood no data n/a 2016 standard therapy France 59
442 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Germany 66
443 peripheral blood chronic lymphocytic leukemia hematology 2016 standard therapy Germany 62
444 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy France 47
445 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy France 67
446 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Lithuania 15
447 peripheral blood Hodgkin’s lymphoma hematology 2016 standard therapy United Kingdom 18
448 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Czech Republic 37
449 peripheral blood acute lymphoblastic leukemia hematology 2016 standard therapy France 24
450 bone marrow severe aplastic anaemia hematology 2016 standard therapy France 9
451 bone marrow no data n/a 2016 standard therapy Poland 7
452 peripheral blood acute lymphoblastic leukemia hematology 2016 standard therapy Canada 13
453 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Hungary 57
454 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Belgium 56
455 bone marrow Hurler syndrome metabolic 2016 standard therapy United Kingdom 2
456 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy France 38
457 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy France 52
458 peripheral blood chronic myelomonocytic leukemia, minimal residual disease hematology 2016 standard therapy Poland 50
459 peripheral blood myeloma multiplex hematology 2016 standard therapy Germany 63
460 peripheral blood Fanconi anaemia hematology 2016 standard therapy Estonia 7
461 peripheral blood plasma cell disorder hematology 2016 standard therapy France 47
462 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Germany 35
463 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Germany 72
464 peripheral blood myeloma multiplex hematology 2016 standard therapy Poland 51
465 peripheral blood acute lymphoblastic leukemia hematology 2016 standard therapy Spain 58
466 bone marrow severe combined immunodeficiency hematology 2016 standard therapy Turkey 4
467 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy Estonia 62
468 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Hungary 46
469 peripheral blood acute lymphoblastic leukemia hematology 2016 standard therapy Hungary 20
470 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Italy 51
471 peripheral blood primary Immunodeficiency hematology 2016 standard therapy Russia 5
472 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy United Kingdom 62
473 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Germany 69
474 bone marrow acute lymphoblastic leukemia hematology 2016 standard therapy Canada 11
475 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Australia 51
476 peripheral blood no data n/a 2016 standard therapy Netherlands 58
477 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Spain 38
478 peripheral blood acute lymphoblastic leukemia hematology 2016 standard therapy Lithuania 23
479 peripheral blood chronic myeloid leukemia hematology 2016 standard therapy Germany 62
480 peripheral blood Hodgkin’s lymphoma hematology 2016 standard therapy Germany 32
481 bone marrow myelofibrosis hematology 2016 standard therapy Germany 31
482 bone marrow DiGeorge syndrome hematology 2016 standard therapy Netherlands 24
483 peripheral blood acute lymphoblastic leukemia hematology 2016 standard therapy Germany 27
484 peripheral blood acute lymphoblastic leukemia hematology 2016 standard therapy Poland 30
485 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Turkey 55
486 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Israel 63
487 peripheral blood acute lymphoblastic leukemia hematology 2016 standard therapy Turkey 37
488 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Germany 66
489 peripheral blood acute lymphoblastic leukemia hematology 2016 standard therapy Turkey 38
490 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Germany 65
491 bone marrow Hodgkin’s lymphoma hematology 2016 standard therapy Italy 17
492 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Poland 46
493 bone marrow acute myelogenous leukemia hematology 2016 standard therapy Belarus 12
494 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Germany 18
495 bone marrow acute lymphoblastic leukemia hematology 2016 standard therapy Belarus 18
496 peripheral blood Hodgkin’s lymphoma hematology 2016 standard therapy Netherlands 38
497 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Turkey 48
498 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy Germany 61
499 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy France 67
500 peripheral blood no data n/a 2016 standard therapy Poland 55
501 bone marrow severe combined immunodeficiency hematology 2016 standard therapy Poland 0,58
502 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy France 32
503 peripheral blood T-cell acute lymphoblastic leukemia hematology 2016 standard therapy Germany 19
504 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy United Kingdom 68
505 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Germany 59
506 peripheral blood myelodysplastic syndrome – RCMD hematology 2016 standard therapy Czech Republic 32
507 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy Belgium 65
508 peripheral blood myelofibrosis hematology 2016 standard therapy Netherlands 66
509 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Switzerland 8/12
510 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Israel 36
511 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Germany 66
512 bone marrow Severe Aplastic Anaemia hematology 2016 standard therapy France 9
513 bone marrow severe aplastic anaemia / paroxymal nocturnal haemoglobinuria hematology 2016 standard therapy Poland 17
514 bone marrow myelodysplastic syndrome hematology 2016 standard therapy Hungary 1
515 bone marrow acute myelogenous leukemia hematology 2016 standard therapy Italy 67
516 bone marrow myelodysplastic syndrome hematology 2016 standard therapy Spain 56
517 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Denmark 68
518 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy Spain 15
519 bone marrow Fanconi anaemia hematology 2016 standard therapy Netherlands 41
520 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy Italy 52
521 peripheral blood chronic myelomonocytic leukaemia hematology 2016 standard therapy Finland 53
522 peripheral blood no data n/a 2016 standard therapy Turkey 4
523 peripheral blood leukemia hematology 2016 standard therapy Lithuania 53
524 peripheral blood T-cell acute lymphoblastic leukemia hematology 2016 standard therapy Serbia 21
525 peripheral blood myeloproliferative syndrome hematology 2016 standard therapy Poland 52
526 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy France 63
527 peripheral blood no data n/a 2016 standard therapy Poland 44
528 bone marrow acute lymphoblastic leukemia hematology 2016 standard therapy France 5
529 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Czech Republic 60
530 peripheral blood T-cell acute lymphoblastic leukemia hematology 2016 standard therapy Austria 41
531 peripheral blood primary myelofibrosis hematology 2016 standard therapy Switzerland 67
532 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy United Kingdom 20
533 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Brazil 37
534 bone marrow acute myelogenous leukemia hematology 2016 standard therapy United Kingdom 29
535 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy France 60
536 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Germany 61
537 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Turkey 51
538 bone marrow acute lymphoblastic leukemia hematology 2016 standard therapy Belarus 25
539 peripheral blood acute lymphoblastic leukemia hematology 2016 standard therapy France 28
540 bone marrow acute lymphoblastic leukemia hematology 2016 standard therapy New Zealand 1
541 bone marrow severe combined immunodeficiency hematology 2016 standard therapy Germany 12
542 bone marrow acute lymphoblastic leukemia hematology 2016 standard therapy Poland 5
543 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Poland 65
544 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Italy 53
545 peripheral blood Lymphoblastic Lymphoma hematology 2016 standard therapy Italy 33
546 peripheral blood acute lymphoblastic leukemia hematology 2016 standard therapy Slovakia 30
547 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy Belgium 9
548 peripheral blood myeloma multiplex hematology 2016 standard therapy Poland 38
549 peripheral blood acute lymphoblastic leukemia hematology 2016 standard therapy Poland 39
550 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy Austria 61
551 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy New Zealand 59
552 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Australia 62
553 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Germany 65
554 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Portugal 41
555 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy France 59
556 peripheral blood SAA / Amyloidosis hematology 2016 standard therapy United Kingdom 45
557 peripheral blood chronic myeloid leukemia hematology 2016 standard therapy Finland 46
558 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Poland 50
559 bone marrow no data n/a 2016 standard therapy Poland 33
560 peripheral blood acute lymphoblastic leukemia hematology 2016 standard therapy Italy 66
561 peripheral blood non-Hodgkin lymphoma hematology 2016 standard therapy Russia 38
562 peripheral blood acute lymphoblastic leukemia hematology 2016 standard therapy Poland 20
563 peripheral blood myelofibrosis hematology 2016 standard therapy France 67
564 peripheral blood B-cell Acute lymphoblastic leukemia hematology 2016 standard therapy Belgium 44

Ultima actualizare: Noiembrie 2016